News

Filter

Current filters:

None

8030 to 8039 of 96157 results

Bayer’s Xarelto gets backing in Scotland

14-02-2012

German drug major Bayer’s (BAY: DE) oral anticoagulant Xarelto (rivaroxaban) has been accepted by…

BayerCardio-vascularEuropePharmaceuticalPricingRegulationXarelto

Rush Bill would make most patent settlement deals in USA unlawful

14-02-2012

Last week, US Representative Bobby Rush (Democrat, Illinois) introduced HR 3995, the Protecting Consumer…

GenericsLegalNorth AmericaPharmaceuticalRegulation

Valeant bags another company, Eyetech

14-02-2012

Acquisitive Canadian drugmaker Valeant Pharmaceuticals International (TSX: VRX) says that it has agreed…

BiotechnologyEyetechMacugenMergers & AcquisitionsOphthalmicsPharmaceuticalValeant Pharmaceuticals

Regeneron ups Eylea forecast, posts 2011 results

14-02-2012

USA-based biotech firm Regeneron Pharmaceuticals (Nasdaq: REGN) saw its shares leap 12% to $114.10 in…

BayerBiotechnologyEyleaFinancialOphthalmicsRegeneronResearch

NICE views breast cancer drugs from GSK and Roche too expensive

14-02-2012

The UK drug watchdog the National Institute for Health and Clinical Excellence (NICE) has published draft…

EuropeGlaxoSmithKlineHerceptinOncologyPharmaceuticalPricingRegulationRocheTyverb

Legal provisions take toll on Actelion

14-02-2012

Switzerland-based Actelion (ATLN: VX), Europe’s largest biotech company, this morning posted full-year…

ActelionBiotechnologyFinancial

US Rx cough/cold deal boosts Vernalis

14-02-2012

UK biotech firm Vernalis (LSE: VER) saw its share price rocket 28% to 25.2 pence last Friday, when the…

BiotechnologyLicensingNorth AmericaResearchRespiratory and PulmonaryTris PharmaVernalis

Strong growth forecast for Russian pharma sector

13-02-2012

Backed by government support and private sector investment, the Russian pharmaceutical market is likely…

EuropeMarkets & MarketingPharmaceuticalPolitics

8030 to 8039 of 96157 results

Back to top